Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-11
1997-01-28
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546330, 546334, 546335, 546336, C07D21357, A61K 3144
Patent
active
055978371
ABSTRACT:
Methods of inhibiting cell proliferation in a patient suffering from such disorder comprising the use of a styryl-substituted heteroaryl compound wherein the heteroaryl group is a monocyclic ring with 1 or 2 heteroatoms, or a bicyclic ring with 1 to about 4 heteroatoms, said compound optionally substituted or polysubstituted, with the proviso that when said ring is polysubstituted, the substituents do not have a common point of attachment to said ring, and those compounds wherein no substituent on the heteroaryl group is a carboxy group or an ester group, and pharmaceutical compositions comprising such compounds.
REFERENCES:
patent: 3157663 (1964-11-01), Bencze
patent: 3196158 (1965-07-01), Bencze
patent: 3337565 (1967-08-01), Bencze et al.
patent: 3337567 (1967-08-01), Walker et al.
patent: 3337568 (1967-08-01), Bencze et al.
patent: 4532329 (1985-07-01), Haken et al.
patent: 4539325 (1985-09-01), Heeres
patent: 4600712 (1986-07-01), Haken et al.
patent: 4626543 (1986-12-01), Kollmeyer
patent: 4678793 (1987-07-01), Klaus et al.
patent: 4769384 (1988-09-01), Kise et al.
patent: 4816476 (1989-03-01), Klaus et al.
patent: 4826984 (1989-05-01), Berlin et al.
patent: 4833247 (1989-05-01), Krause
Bencze et al, Chemical Abstracts, vol. 59, Abstract No. 11,449d, 1963.
Kakimoto et al, Chemical Abstracts, vol 54, Abstract No. 21,080b, 1960.
S. Kusuma, W. D. Wilson and D. W. Boykin, J. Heterocyclic Chem., 22, 1229 (1985).
T. Kato, t. Shiraishi and T. Atsumi, Yakugaku Zasshi, 89(2) pp. 188-193 (1969).
Persons Paul E.
Spada Alfred P.
Davis Zinna Northington
Rh one-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Method and composition for treating psoriasis with styryl-substi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treating psoriasis with styryl-substi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating psoriasis with styryl-substi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941743